Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional, Non-comparative, Single-center Post Marketing Clinical Follow-up (PMCF) Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops"

NCT05824000 is registered in ClinicalTrials.gov with C.O.C. Farmaceutici S.r.l. as lead sponsor.

NCT NCT05824000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05824000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional, Non-comparative, Single-center Post Marketing Clinical Follow-up (PMCF) Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops"
Lead sponsor
C.O.C. Farmaceutici S.r.l.
Phase
Not applicable
Overall status
Completed
Start date
June 7, 2022
Completion date
August 5, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis, dry eye, dry eye disease